Car buying experts say despite the warning of price hikes due to tariffs, the worst is yet to come. It might be the summer of ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

What implications does this carry for Ford and investors? The consequences are serious. Quality issues could damage consumer ...

Ford is outperforming the S&P 500 with strong Q1 results, solid cash flow, and bullish technicals, despite tariff risks. Find ...

Following employee pricing is another incentive push. If you follow Ford Motor Company (NYSE: F), or perhaps the auto ...

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

The inside story of how a CEO and a group of marketers made a last-minute change of plans that now has the Ford brand leading ...

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

Detailed price information for Ford Motor Company (F-N) from The Globe and Mail including charting and trades.

The GMC Hummer EV outperformed Tesla's Cybertruck in the second quarter of 2025, with sales figures revealing a significant drop in Cybertruck purchases.